Načítá se...
Trastuzumab
Trastuzumab is standard of care in the treatment of human epidermal growth factor receptor (HER)-2(+) early and advanced breast cancer. Recently, it has been approved for the treatment of HER-2(+) advanced gastric cancer. Trastuzumab is an IgG1 humanized monoclonal antibody administered by intraveno...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AlphaMed Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228213/ https://ncbi.nlm.nih.gov/pubmed/21632460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|